JP2002527387A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527387A5
JP2002527387A5 JP2000575500A JP2000575500A JP2002527387A5 JP 2002527387 A5 JP2002527387 A5 JP 2002527387A5 JP 2000575500 A JP2000575500 A JP 2000575500A JP 2000575500 A JP2000575500 A JP 2000575500A JP 2002527387 A5 JP2002527387 A5 JP 2002527387A5
Authority
JP
Japan
Prior art keywords
ara
use according
dha
ratio
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000575500A
Other languages
English (en)
Other versions
JP2002527387A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/007834 external-priority patent/WO2000021524A1/en
Publication of JP2002527387A publication Critical patent/JP2002527387A/ja
Publication of JP2002527387A5 publication Critical patent/JP2002527387A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項１】
授乳中の女性のための食餌または栄養サプリメントとしてのＡＲＡの使用。
【請求項２】
ＡＲＡが１５０〜７００ｍｇ／日で摂取される請求項１記載の使用。
【請求項３】
ＡＲＡが２５０〜５００ｍｇ／日で摂取される請求項１または２記載の使用。
【請求項４】
女性の母乳中のＡＲＡのレベルを増加させるための前記請求項のいずれかに記載の使用。
【請求項５】
さらにＤＨＡを含むものである前記請求項のいずれかに記載の使用。
【請求項６】
ＡＲＡおよびＤＨＡが血中のＡＲＡレベルを増加させるＡＲＡ：ＤＨＡ比にて食用処方物に存在するものである、請求項５記載の使用。
【請求項７】
ＡＲＡ：ＤＨＡの比が１：５〜５：１である請求項５または６記載の使用。
【請求項８】
ＡＲＡ：ＤＨＡの比が１：１〜１：２である請求項７記載の使用。
JP2000575500A 1998-10-15 1999-10-15 Ｐｕｆａサプリメント Pending JP2002527387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98308403 1998-10-15
EP98308403.9 1998-10-15
PCT/EP1999/007834 WO2000021524A1 (en) 1998-10-15 1999-10-15 Pufa supplements

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010268487A Division JP2011098966A (ja) 1998-10-15 2010-12-01 Ｐｕｆａサプリメント

Publications (2)

Publication Number Publication Date
JP2002527387A JP2002527387A (ja) 2002-08-27
JP2002527387A5 true JP2002527387A5 (ja) 2006-12-07

Family

ID=8235104

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000575500A Pending JP2002527387A (ja) 1998-10-15 1999-10-15 Ｐｕｆａサプリメント
JP2010268487A Pending JP2011098966A (ja) 1998-10-15 2010-12-01 Ｐｕｆａサプリメント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010268487A Pending JP2011098966A (ja) 1998-10-15 2010-12-01 Ｐｕｆａサプリメント

Country Status (13)

Country Link
US (2) US20070184090A1 (ja)
EP (4) EP2308486A1 (ja)
JP (2) JP2002527387A (ja)
CN (3) CN1326344A (ja)
AT (1) ATE361066T1 (ja)
AU (2) AU775421B2 (ja)
CA (2) CA2355341C (ja)
DE (1) DE69935995T3 (ja)
DK (1) DK1121115T4 (ja)
ES (1) ES2284286T5 (ja)
HK (1) HK1042441A1 (ja)
NZ (1) NZ511071A (ja)
WO (1) WO2000021524A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
WO2002026946A2 (en) 2000-09-28 2002-04-04 Bioriginal Food & Science Corporation Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
CN1259044C (zh) * 2001-03-30 2006-06-14 日清奥利友集团株式会社 骨代谢改善剂
JP2003048831A (ja) * 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
AU778384B2 (en) * 2001-11-14 2004-12-02 Virtus Nutrition Llc Method for manufacturing fatty acid calcium salts from high glyceride content oils
US7820842B2 (en) 2004-04-30 2010-10-26 Virtus Nutrition Llc Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
CN101837136B (zh) * 2002-06-19 2014-05-28 帝斯曼知识产权资产管理有限公司 微生物油
JP4771697B2 (ja) * 2002-09-24 2011-09-14 サントリーホールディングス株式会社 認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
WO2004095940A1 (en) * 2003-04-25 2004-11-11 The University Of Newcastle Biomass containing animal feed
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
CN1997425B (zh) * 2004-07-01 2010-10-13 雀巢技术公司 犬骨关节炎饮食配方
ES2253089B1 (es) * 2004-07-16 2007-08-16 Berthol Victor Laboratorios Ordesa, S.L. Complemento nutraceutico para la preparacion de leches infantiles.
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP2006083136A (ja) * 2004-09-17 2006-03-30 Suntory Ltd ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
EP1772146A1 (en) * 2005-10-03 2007-04-11 Neuropharma, S.A. Polyunsaturated fatty acids as bace inhibitors
EP2098229A4 (en) 2006-12-28 2010-03-10 Suntory Holdings Ltd NERVE REGENERATION AGENT
US20090202672A1 (en) * 2008-02-11 2009-08-13 Monsanto Company Aquaculture feed, products, and methods comprising beneficial fatty acids
CN101259101B (zh) * 2008-04-17 2010-06-02 湖北福星生物科技有限公司 微米级花生四烯酸和二十二碳六烯酸乳状液及其制备方法
GB2460056A (en) * 2008-05-14 2009-11-18 Arab Science & Technology Foun Compositions comprising omega-6 fatty acids for use in treating schistosomiasis
EP2493296B1 (en) 2009-10-30 2019-01-09 Retrotope, Inc. Alleviating oxidative stress disorders with pufa derivatives
US10154978B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Disorders implicating PUFA oxidation
KR102020611B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 Ｐｕｆａ와 관련된 신경퇴행성 질환 및 근육 질환
AU2012249918B2 (en) 2011-04-26 2017-06-15 Biojiva Llc Impaired energy processing disorders and mitochondrial deficiency
EP3689342A1 (en) * 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative retinal diseases
EP2745706A1 (en) * 2012-12-24 2014-06-25 Abbott Laboratories, Inc. Methods for maintaining bone quality
KR102615285B1 (ko) 2013-12-20 2023-12-19 마라 리뉴어블즈 코퍼레이션 미생물로부터 오일을 회수하는 방법
MA41611A (fr) * 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
WO2017091279A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
CA3172351A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
WO2024050589A1 (en) * 2022-09-07 2024-03-14 Nourish Ingredients Pty Ltd Compositions and methods for producing meat-like aromas

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids
ZA92452B (en) * 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
PH11992043811B1 (en) 1991-01-24 2002-08-22 Martek Corp Arachidonic acid and methods for the production and use thereof
US5658767A (en) * 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
JPH0692848A (ja) * 1992-09-11 1994-04-05 Sagami Chem Res Center 糖尿病治療用乳剤
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
JPH06271464A (ja) * 1993-03-19 1994-09-27 Tokiwa Yakuhin Kogyo Kk 消化器系障害の予防または治療用アラキドン酸含有組成物
ATE264099T1 (de) * 1993-06-09 2004-04-15 Martek Biosciences Corp Für die behandlung neurologischer erkrankungen nützliche methoden und pharmazeutische zusammensetzungen
JPH07267856A (ja) * 1994-02-09 1995-10-17 Green Cross Corp:The 経口免疫抑制剤
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
EP1886679A3 (en) * 1995-06-07 2008-05-28 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
DE69735098T3 (de) 1996-03-26 2013-01-31 Dsm Ip Assets B.V. Späte zugabe von polyungesättigten fettsäuren in einem herstellungsverfahren von säuglingsnahrung
EP0893953B1 (en) 1996-03-26 2002-06-05 Dsm N.V. Pufa coated solid carrier particles for foodstuff
EP2280062A3 (en) 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
JP4545235B2 (ja) 1996-03-28 2010-09-15 ディーエスエム アイピー アセッツ ビー．ブイ． 顆粒状微生物バイオマスの製造法とそのバイオマスからの貴重化合物の単離法
FR2749133A1 (fr) * 1996-06-04 1997-12-05 Pierre Moreau Obtention d'oeufs specifiquement enrichis en acide cervonique (acide docosahexaenoique ou dha). applications alimentaires, therapeutiques et industrielles de ces oeufs et de leurs extraits lipidiques
JP3792309B2 (ja) * 1996-08-30 2006-07-05 サントリー株式会社 不飽和脂肪酸含有油脂の製造方法
JP4633204B2 (ja) * 1996-10-11 2011-02-16 サントリーホールディングス株式会社 アラキドン酸含有食用油脂およびそれを含有する食品

Similar Documents

Publication Publication Date Title
JP2002527387A5 (ja)
CN1662224B (zh) 用于产生厌腻效应和用于减轻体重的药剂
CA2355341A1 (en) The use of ara as a supplement for a lactating woman
CA2294099A1 (en) Absorption of minerals
CN105054025A (zh) 一种用于炎症性肠病患者的低脂低渗低渣型肠内营养粉剂
HK1047017B (zh) 凝膠性營養組合物和製備方法
SI1181047T1 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
HK1080332A1 (en) Human milk supplement
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
CA2285552A1 (en) Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
US20130034630A1 (en) Reload energy gel for athletes and active adults
EP1797887A4 (en) MEDICAMENT FOR REDUCING THE INFLAMMATION OF NEUTRAL FAT IN THE BLOOD AFTER A MEAL AND THE FOOD CONTAINING THEREOF
CA2335713A1 (en) Oral dosage form
JP2005000033A (ja) 食品
US6372264B1 (en) Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
EP1121865A3 (en) A medical composition for the treatment and/or prevention of malnutrition
EP0425423B1 (en) A process for the preparation of a low-calorie nutritional preparation
JPH10218785A (ja) 滋養強壮剤
HK1036203A1 (en) Food supplements comprising lipoic acid and creatine and methods for their use
Winkvist et al. Malnourished Mothers Maintain their Weight Through out Pregnancy and Lactation: Results From Guatemala
CN2369500Y (zh) 增强男子性功能的保健内裤
DE20307098U1 (de) Nahrungsergänzungspräparat
Lantin Set your heart on eating well
JPS6037953A (ja) カルシウムを主成分とする栄養補助食品
RU99105659A (ru) Лекарственное средство "растоспир", обладающее гепатопротекторным, иммуномодулирующим и антиоксидантным действием и биологически активная добавка на его основе